Does hybridoma technology still have a place in transfusion medicine?

Abstract:

:Hybridoma technology has contributed to virtually all areas of biology and medicine and set the scene for important advances in cell biology and immunodiagnostics. Blood transfusion and transfusion medicine have benefited significantly from development in hybridoma technology, and this has resulted in the generation of a wide range of monoclonal antibodies to human blood group antigens. These antibodies have also had an impact on diagnostic techniques such as enzyme-linked immunosorbent assay and flow cytometry as well as on the application of therapeutic agents in the clinical environment. However, rapid advances in the development of knockout and transgenic mice as well as in nucleic acid-based immunization may well lead hybridoma technology into a new era.

journal_name

Transfus Med Rev

authors

Yuan FF,Watt JM,Geczy AF

doi

10.1053/tmrv.2002.33436

subject

Has Abstract

pub_date

2002-07-01 00:00:00

pages

230-8

issue

3

eissn

0887-7963

issn

1532-9496

pii

S0887-7963(02)80056-6

journal_volume

16

pub_type

杂志文章,评审
  • The impact of Creutzfeldt-Jakob disease and variant Creutzfeldt-Jakob disease on plasma safety.

    abstract::Although the true risk of transmitting (classical) Creutzfeld-Jakob Disease (CJD) and variant CJD (vCJD) via transfusion is likely very minimal, a review of prions and the impact of these associated prion diseases is timely because of their current effect on safety policies in the blood-plasma industry. Various types ...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1053/tm.2001.25382

    authors: Hoots WK,Abrams C,Tankersleydagger D

    更新日期:2001-04-01 00:00:00

  • Is human herpesvirus-8 transmitted by transfusion?

    abstract::Studies of human herpesvirus-8 (HHV-8) transmission through transfusion have produced contradictory results. In North America-a region with a low prevalence of HHV-8 infection-3 studies that tested specimens from linked positive-donor/negative-recipient pairs collected before the introduction of white blood cell (WBC)...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.tmrv.2009.09.001

    authors: Vamvakas EC

    更新日期:2010-01-01 00:00:00

  • The Canadian blood donor health assessment questionnaire: lessons from history, application of cognitive science principles, and recommendations for change.

    abstract::Over the last 20 years, the Canadian Blood Services' (CBS) Donor Health Assessment Questionnaire (DHAQ), used to screen prospective blood donors to determine their eligibility, has grown in complexity and length. Its growth is inextricably linked to the evolution of the environment within which CBS operates from unreg...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.tmrv.2007.03.002

    authors: O'Brien SF,Ram SS,Vamvakas EC,Goldman M

    更新日期:2007-07-01 00:00:00

  • Donor deferral registries.

    abstract::In the last half of this century, donor deferral registries have grown in size, scope, and importance for blood collection organizations and regulatory agencies. This has occurred despite the lack of direct evidence that, when used with all other methods, they contribute meaningfully to the safety of the blood supply....

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/s0887-7963(93)70131-5

    authors: Sherwood WC

    更新日期:1993-04-01 00:00:00

  • Proceedings of a Consensus Conference: pathogen inactivation-making decisions about new technologies.

    abstract::Significant progress has been made in reducing the risk of pathogen transmission to transfusion recipients. Nonetheless, there remains a continuing risk of transmission of viruses, bacteria, protozoa, and prions to recipients. These include many of the viruses for which specific screening tests exist as well as pathog...

    journal_title:Transfusion medicine reviews

    pub_type: 共识发展会议,杂志文章,评审

    doi:10.1016/j.tmrv.2007.09.001

    authors: Webert KE,Cserti CM,Hannon J,Lin Y,Pavenski K,Pendergrast JM,Blajchman MA

    更新日期:2008-01-01 00:00:00

  • Clinical trial opportunities in Transfusion Medicine: proceedings of a National Heart, Lung, and Blood Institute State-of-the-Science Symposium.

    abstract::The use of blood products to support patients undergoing the large variety of medical and surgical interventions requiring such support has continued to escalate very significantly over time. Relevantly, significant practice variation in the use of blood products exists among practitioners and institutions, largely be...

    journal_title:Transfusion medicine reviews

    pub_type:

    doi:10.1016/j.tmrv.2010.05.002

    authors: Blajchman MA,Glynn SA,Josephson CD,Kleinman SH,State-of-the Science Symposium Transfusion Medicine Committee.

    更新日期:2010-10-01 00:00:00

  • The management of blood safety in the presence of uncertain risk: a United kingdom perspective.

    abstract::Millions of patients in the UK benefit from the use of both plasma derivatives and blood components that are seen as critical interventions in current medicine. Measures are in place to significantly reduce the risks associated with blood transfusion and plasma derivatives; however, these measures themselves are not r...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.tmrv.2011.09.003

    authors: Watkins NA,Dobra S,Bennett P,Cairns J,Turner ML

    更新日期:2012-07-01 00:00:00

  • Camouflaged blood cells: low-technology bioengineering for transfusion medicine?

    abstract::The small number of studies done on the covalent modification of RBC with PEG, or PEG-derivatives, suggests that the immunocamouflage of intact cells significantly reduces the antigenicity and immunogenicity of the foreign cell. Importantly, this protective immunologic effect can be accomplished without adversely affe...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/s0887-7963(00)80115-7

    authors: Scott MD,Bradley AJ,Murad KL

    更新日期:2000-01-01 00:00:00

  • Red Blood Cell Alloimmunization in Transfused Patients With Sickle Cell Disease in Sub-Saharan Africa; a Systematic Review and Meta-Analysis.

    abstract::Sickle cell disease (SCD) is the most common monogenic disorder in sub-Saharan Africa (SSA). Blood transfusion to increase the oxygen carrying capacity of blood is vital in the management of many patients with SCD. However, red blood cell (RBC) alloimmunization is a major challenge to transfusions in these patients. C...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,meta分析

    doi:10.1016/j.tmrv.2019.06.003

    authors: Boateng LA,Ngoma AM,Bates I,Schonewille H

    更新日期:2019-07-01 00:00:00

  • Hemostatic and signaling functions of transfused platelets.

    abstract::Metabolic studies have revealed a gradual impairment in platelet integrity during storage, a process termed the platelet storage lesion. Recent evidence shows that stored platelets also lose signaling responses to physiological agonists with impaired integrin activation, secretion, and aggregation of the cells. On the...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.tmrv.2007.05.004

    authors: Cauwenberghs S,van Pampus E,Curvers J,Akkerman JW,Heemskerk JW

    更新日期:2007-10-01 00:00:00

  • Meeting the clinical challenge of care for Jehovah's Witnesses.

    abstract::Quality patient care entails more than simply biomedical interventions. Respect for the wishes, values, and preferences of patients are important elements of quality care. Unique aspects of the beliefs of Jehovah's Witnesses may present physicians with ethical and clinical conflicts. Witnesses believe that allogeneic ...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.tmrv.2003.12.004

    authors: Bodnaruk ZM,Wong CJ,Thomas MJ

    更新日期:2004-04-01 00:00:00

  • Platelet derivatives in regenerative medicine: an update.

    abstract::Prior preclinical and clinical studies support the use of platelet-derived products for the treatment of soft and hard tissue lesions. These regenerative effects are controlled by autocrine and paracrine biomolecules including growth factors and cytokines contained in platelet alpha granules. Each growth factor is inv...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.tmrv.2014.11.001

    authors: De Pascale MR,Sommese L,Casamassimi A,Napoli C

    更新日期:2015-01-01 00:00:00

  • Evolution and Utility of Antiplatelet Autoantibody Testing in Patients with Immune Thrombocytopenia.

    abstract::To this day, immune thrombocytopenia (ITP) remains a clinical diagnosis made by exclusion of other causes for thrombocytopenia. Reliable detection of platelet autoantibodies would support the clinical diagnosis, but the lack of specificity and sensitivity of the available methods for platelet autoantibody testing limi...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.tmrv.2020.09.003

    authors: Porcelijn L,Schmidt DE,Oldert G,Hofstede-van Egmond S,Kapur R,Zwaginga JJ,de Haas M

    更新日期:2020-10-01 00:00:00

  • The regulation of complement on cell surfaces.

    abstract::The regulation of complement at the surface of cells is mediated by both plasma and membrane proteins. These molecules act in concert to prevent the accelerated catabolism of complement proteins and the concomitant lysis of homologous blood cells. The deficiency of either a plasma or membrane protein predisposes to th...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/s0887-7963(91)70199-5

    authors: Devine DV

    更新日期:1991-04-01 00:00:00

  • Neonatal Platelet Transfusions and Future Areas of Research.

    abstract::Thrombocytopenia affects approximately one fourth of neonates admitted to neonatal intensive care units, and prophylactic platelet transfusions are commonly administered to reduce bleeding risk. However, there are few evidence-based guidelines to inform clinicians' decision-making process. Developmental differences in...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.tmrv.2016.05.009

    authors: Sola-Visner M,Bercovitz RS

    更新日期:2016-10-01 00:00:00

  • Appropriateness of allogeneic red blood cell transfusion: the international consensus conference on transfusion outcomes.

    abstract::An international multidisciplinary panel of 15 experts reviewed 494 published articles and used the RAND/UCLA Appropriateness Method to determine the appropriateness of allogeneic red blood cell (RBC) transfusion based on its expected impact on outcomes of stable nonbleeding patients in 450 typical inpatient medical, ...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,多中心研究,评审

    doi:10.1016/j.tmrv.2011.02.001

    authors: Shander A,Fink A,Javidroozi M,Erhard J,Farmer SL,Corwin H,Goodnough LT,Hofmann A,Isbister J,Ozawa S,Spahn DR,International Consensus Conference on Transfusion Outcomes Group.

    更新日期:2011-07-01 00:00:00

  • The challenge of platelet alloimmunization: management and prevention.

    abstract::The limiting factor in platelet transfusion therapy is the development of alloimmunization. Although using HLA matched platelets may be effective in reducing the problem of alloimmune platelet transfusion refractoriness, relying solely upon HLA matching has its shortcomings. The selection of compatible platelet transf...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/s0887-7963(90)70237-4

    authors: Kickler TS

    更新日期:1990-10-01 00:00:00

  • Electronic crossmatching.

    abstract::The crossmatch (XM) is an important part of routine pretransfusion testing. It is used to detect ABO incompatibility and other clinically significant antibodies. The XM has been modified many times and, in recent years, has been abbreviated. The 2 common types of XM currently being done are the immediate spin XM for a...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.tmrv.2005.08.007

    authors: Arslan O

    更新日期:2006-01-01 00:00:00

  • What a difference 2 nucleotides make: a short review of ABO genetics.

    abstract::ABO is the most important blood group system for transfusion and solid organ transplantation, but it is only over the past 15 years that the techniques for studying its molecular basis became mainstream. Many of its common and rare alleles are now well characterized and by using various expression systems, their effec...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.tmrv.2005.02.003

    authors: Yazer MH

    更新日期:2005-07-01 00:00:00

  • The Role of Complement in Hereditary Angioedema.

    abstract::Low levels of C1 inhibitor, the main inhibitor of the classic complement system, result in paroxysmal angioedema attacks that can be incapacitating or even life-threatening in affected individuals. Molecular defects in the gene for C1 inhibitor cause hereditary angioedema. In recent years, new insights in the pathways...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.tmrv.2019.08.002

    authors: Levi M,Cohn DM

    更新日期:2019-10-01 00:00:00

  • Chromosome location of genes encoding human blood groups.

    abstract::The chromosomal locations of genes controlling the expression of some 200 antigens constituting the 23 established human blood group systems have been reviewed. Twenty-one of the these genes are located on 12 autosomes, and two are located on the X chromosome. Refined chromosomal positions, to a single cytogenetically...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/s0887-7963(98)80056-4

    authors: Reid ME,McManus K,Zelinski T

    更新日期:1998-07-01 00:00:00

  • Single- Versus Double-Unit Umbilical Cord Blood Transplantation for Hematologic Diseases: A Systematic Review.

    abstract::Controversial results exist regarding the clinical benefits of single- vs double-unit umbilical cord blood transplantation (UCBT) in patients with hematologic diseases. A systematic review was conducted to evaluate this issue. The PubMed, Embase, and Cochrane Library databases were searched up to May 2018. A total of ...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章

    doi:10.1016/j.tmrv.2018.11.001

    authors: Wang L,Gu ZY,Liu SF,Ma DX,Zhang C,Liu CJ,Gao R,Guan LX,Zhu CY,Wang FY,Gao CJ,Wei HP

    更新日期:2019-01-01 00:00:00

  • Ex vivo production of human red blood cells from hematopoietic stem cells: what is the future in transfusion?

    abstract::There is difficulty in obtaining adequate supplies of blood components, as well as disappointing performance of stabilized or recombinant hemoglobins, limited indications of oxygen transporters (perfluorocarbons), and slow development of "universal" red blood cells (RBCs). There is, therefore, a need for complementary...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.tmrv.2006.11.004

    authors: Douay L,Andreu G

    更新日期:2007-04-01 00:00:00

  • Can blood tranfusion transmit cancer? A literature review.

    abstract::Blood services around the world face increasing challenges in recruiting voluntary blood donors. With increasing donor restrictions and ageing populations, it is essential to look for any existing restrictions that may be relaxed in the light of currently available evidence. We propose that one such restriction is the...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.tmrv.2010.03.005

    authors: Yang H,Lee J,Seed CR,Keller AJ

    更新日期:2010-07-01 00:00:00

  • Cost-effectiveness analysis: what it really means for transfusion medicine decision making.

    abstract::Some have suggested that "blood is different," and the role for cost-effectiveness is thus circumscribed. In this article, the authors start by reviewing key concepts in health economics and economic analysis methods. Examples are drawn from published blood safety studies. After explaining the underlying reasoning beh...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.tmrv.2008.09.001

    authors: Custer B,Hoch JS

    更新日期:2009-01-01 00:00:00

  • Protecting the blood supply from emerging pathogens: the role of pathogen inactivation.

    abstract::Although the risk of infection by blood transfusion is relatively low, breakthrough infections still occur, Transfusion-related fatalities caused by infections continue to be reported, and blood is not tested for many potentially dangerous pathogens. The current paradigm for increasing the safety of the blood supply i...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.tmrv.2004.11.005

    authors: Allain JP,Bianco C,Blajchman MA,Brecher ME,Busch M,Leiby D,Lin L,Stramer S

    更新日期:2005-04-01 00:00:00

  • Comparative Risk of Hypophosphatemia Following the Administration of Intravenous Iron Formulations: A Network Meta-Analysis.

    abstract::Intravenous iron therapy is increasingly used in patients with iron deficiency anemia, although concerns of hypophosphatemia have been recently raised. The aim of this study was to evaluate different intravenous iron formulations for the risk of hypophosphatemia. Medline, Scopus, Cochrane Central Register of Controlle...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.tmrv.2020.07.002

    authors: Bellos I,Frountzas M,Pergialiotis V

    更新日期:2020-07-01 00:00:00

  • Platelet Immunology in China: Research and Clinical Applications.

    abstract::Immunization against human platelet alloantigens (HPAs) is associated with a number of clinical complications. The detection and identification of clinically relevant platelet antibodies are important for the diagnosis and management of patients affected with immune-mediated thrombocytopenias. Human platelet alloantig...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.tmrv.2016.12.001

    authors: Wu G,Zhou Y,Li L,Zhong Z,Li H,Li H,Yu M,Shen W,Ni H

    更新日期:2017-04-01 00:00:00

  • Passenger Lymphocyte Syndrome; a Review of the Diagnosis, Treatment, and Proposed Detection Protocol.

    abstract::Passenger lymphocyte syndrome (PLS) is caused by the transfer of B-lymphocytes present in the donor graft into the recipient circulation following solid organ or hematopoietic stem cell transplantation. These cells may produce antibodies against the recipient's red blood cells, thereby triggering antibody dependent cy...

    journal_title:Transfusion medicine reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.tmrv.2020.06.004

    authors: Moosavi MM,Duncan A,Stowell SR,Roback JD,Sullivan HC

    更新日期:2020-07-01 00:00:00

  • James Blundell, Obstetrical Hemorrhage, and the Origins of Transfusion Medicine.

    abstract::Although James Blundell is rightly acknowledged as the father of modern transfusion therapy, a review of the events surrounding the initial human-to-human transfusions in the first decades of the 19th century reveals substantial contributions by Blundell's collaborators. Bundell's uncle John Haighton provided substant...

    journal_title:Transfusion medicine reviews

    pub_type: 传,历史文章,杂志文章,评审

    doi:10.1016/j.tmrv.2018.08.003

    authors: Dzik S

    更新日期:2018-10-01 00:00:00